?
Serafini-Lamanna Tony
Executive VP-Diagnostics
Meridian Bioscience, Inc.
US, Cincinnati [HQ]
CIK
1812602
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
18,093
Price per Share :
$33.97
Equivalence :
$614,619.21
Transaction History
-
J18,093 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/15/21
-
Footnotes
-
-
Footnotes:#1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.#2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 12,320 on November 15, 2022; and (iii) 10,823 on November 15, 2023.
-
A42,436 Shares After TransactionValue : $n/a$0.0Transaction Date : 11/15/21
-
Footnotes
-
-
Footnotes:#1 Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.#2 Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 12,320 on November 15, 2022; and (iii) 10,823 on November 15, 2023.
-
A43,338 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/31/23
-
Footnotes
-
-
Footnotes:#1 Represents 7,945 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units ("PSUs") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below).#2 The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled.
-
D0.0 Shares After TransactionValue : $n/a$0.0Transaction Date : 01/31/23
-
Footnotes
-
-
Footnotes:#1 Represents 7,945 shares of the Issuer's common stock awarded to the Reporting Person upon the vesting of a portion of an award of performance stock units ("PSUs") in connection with the closing of the transactions contemplated by the Merger Agreement (as defined below).#2 The shares were disposed of pursuant to the Agreement and Plan of Merger dated as of July 7, 2022 (the "Merger Agreement") by and among the Issuer and SD Biosensor, Inc., a corporation with limited liability organized under the laws of the Republic of Korea whereby, immediately prior to the effective time of the merger contemplated therein (the "Effective Time"), all issued and outstanding shares of Issuer common stock were converted into the right to receive $34.00 per share in cash and, when so converted, automatically cancelled.
-
F39,847 Shares After TransactionValue : $1,280,682.58$11,473.98Transaction Date : 09/16/22
-
Footnotes
-
-
Footnotes:#1 Represent restricted stock units withheld by the Company under the net share settlement method to cover certain taxes due upon vesting of units granted on November 15, 2021.